Healthy Clinical Trial
Official title:
An Intervention Study to Assess the Bioavailability of Sulforaphane Delivered by Glucoraphanin-enriched Broccoli Soups in Healthy Subjects
There is current evidence that suggests eating cruciferous vegetables like broccoli,
cauliflower, cabbage is beneficial to our health as they contain compounds which are thought
to reduce the risk of diseases such as cancer and cardiovascular diseases. Cruciferous
vegetables are able to deliver in our body a group of compounds called isothiocyanates
(ITCs) that are thought to be responsible of their health-promoting effects. Sulforaphane
(SF) from broccoli is one of the most studied ITCs and its anticancer properties have been
extensively investigated in in vitro and in vivo models.
The investigators propose to undertake an intervention study to measure the bioavailability
of SF from the soups used in another intervention study called ESCAPE. The investigators
would like to investigate the rate and extent to which SF reaches the systemic circulation
and is excreted in urine by measuring SF and its metabolites in plasma and urine samples
collected from apparently healthy participants after consumption of the three types of
broccoli + stilton soups. The three types of soups are standard broccoli + stilton soups and
two high-glucoraphanin (SF precursor) broccoli + stilton soups which are able to deliver
different levels of SF.
This study has been funded by Biotechnology and Biological Sciences Research Council (BBSRC)
and Prostate Cancer foundation (PCF).
This study will be a randomized, double-blinded, three-phase crossover trial which will
investigate the bioavailability of SF following consumption of broccoli + stilton soup
containing different concentrations of glucoraphanin.
The study population will consist of non-smoking men and women aged between 18 and 65 years
old. Participants will undergo three phases separated by a minimum of two weeks (wash-out
period). Each phase will consist of a 48 hour pre-intervention diet restriction, a study day
involving an 8 hour cannulation at the Human Nutrition Unit (HNU) of the Institute of Food
Research (IFR) and collection of a 24 hour urine and blood sample the following morning.
Participants will be randomly allocated to one of the three soups in each phase. The
following soups will be tested in the three phases: i) 300g standard broccoli + stilton
soup, ii) 300g Beneforte® broccoli + stilton soup, iii) 300g Beneforte Extra broccoli +
stilton soup.
Beneforte and Beneforte extra broccoli are especially cultivated to deliver high
sulforaphane levels after consumption. All the three broccoli varieties have the same
appearance and flavour thus enabling a blinded human intervention study to be undertaken.
Broccoli soups will be manufactured by a food company that supplies soups to the leading
supermarket retailers in the United Kingdom.
Each phase will consist of a 48 hour pre-intervention diet restriction, a study day (study
day 1) comprising of approximately a nine hour stay at the HNU which will involve
cannulation. The following morning participants will visit the HNU for up to 1 hour for
collection of a single blood sample at 24 hour post-dose followed by breakfast. During study
day 1, eleven 10ml blood samples will be collected over the course of the day from
participants at the following timepoints: 0, 30, 45, 60, 90, 120, 180, 240, 360, 480 mins
and a 24 hour blood sample. Six urine samples will be collected at the following timepoints:
0, 0-2, 2-4, 4-6, 6-8, 8-24 hours.
The three phases will be separated by a minimum of a two week washout period. For the
duration of the study, participants will be required to follow a glucosinolate-free diet for
a total of nine days which will be three days per phase. The three days are split into 48
hours (2 days) prior to the study day, 24 hours (1 day) on the study day as well as the
following morning until the 24 hour blood and urine sample have been collected. After the 24
hour urine and blood samples have been collected, participants can resume their normal diet
for a minimum of two weeks until 48 hours prior to their next study day. This will reduce
the contribution of glucosinolate from other foods having an impact on the results of the
study. The involvement of the participants will last approximately 11-12 weeks.
;
Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |